Apax Partners’ Funds acquire Healthcare leader Marken
8 December 2009
London, 8 December 2009 – A consortium comprising funds advised by Apax Partners and company management has reached agreement to acquire Marken, a company specialising in clinical trial logistics, for an undisclosed sum from Intermediate Capital Group. The transaction is subject to the relevant anti-trust clearances and is expected to complete in early 2010.
Healthcare is one of the five sectors in which Apax Partners focuses exclusively. Significant recent investments by the Apax Partners Healthcare team include: General Healthcare Group (the largest private hospital group in the UK), Capio (a leading pan-European hospital group), Unilabs (a leading European clinical laboratory business), Apollo (India’s largest private hospital group), Trizetto (a leading healthcare IT company in the US) and Qualitest (the 6th largest generic pharmaceutical manufacturer in the US).
Khawar Mann, Partner and Global Co-Head of the Apax Healthcare team, commented: “We are delighted to have the opportunity to back Marken and its excellent management team. Marken is a world leader in providing clinical logistics services to the biopharma industry, and its top quality offering means that it is poised for substantial growth as the industry continues the process of globalisation. Apax Partners’ considerable expertise in healthcare and our global network means we are the natural partners to assist Marken in the next phase of its growth.”
For further information, please contact:
Tel: +44 (0)20 7872 6401
NOTES TO EDITORS
About Apax Partners
Apax Partners is one of the world’s leading private equity investment groups. It operates across the United States, Europe and Asia and has more than 30 years of investing experience. Funds under the advice and management of Apax Partners globally total around $40 billion. These Funds provide long-term equity financing to build and strengthen world-class companies. Apax Partners Funds invest in companies across its global sectors of Tech & Telecom, Retail & Consumer, Media, Healthcare and Financial & Business Services.
Marken is one of the fastest growing specialised logistics and support services companies to the biopharmaceutical industry, fulfilling a key role in the early phase II + III stages of research and drug development. Its services include export of trial medication, vaccines and clinical trial material, cold-chain management, protocol support and regulatory advice, investigator liaison and biological sample movement on a global basis. Marken’s clients and partners include pharmaceutical and biotechnology companies, Contract Research Organisations, clinical trial supply companies and academic and government organisations.